Medtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.
Follow MDT
Medtronic PLC (MDT) Return on assets
Medtronic PLC's return on assets over the twelve months to 31 July 2026 was 5.68%, up 0.5 percentage points from fiscal 2026 (5.20%). Over the past ten years it has ranged from 3.25% (fiscal 2018) to 5.48% (fiscal 2022); the current reading is higher than 83% of that period. That is above the Medical Devices industry median of −19.7% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2026 | 5.20% | 0.07 |
| FY2025 | 5.13% | 1.07 |
| FY2024 | 4.06% | (0.07) |
| FY2023 | 4.13% | (1.35) |
| FY2022 | 5.48% | 1.56 |
| FY2021 | 3.92% | (1.39) |
| FY2020 | 5.31% | 0.20 |
| FY2019 | 5.11% | 1.86 |
| FY2018 | 3.25% | (0.79) |
| FY2017 | 4.04% | 0.61 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| DXCM DexCom, Inc. compare | 14.5% |
| BSX Boston Scientific Corporation compare | 8.47% |
| SYK Stryker Corporation compare | 7.91% |
| STE STERIS plc compare | 7.62% |
| EW Edwards Lifesciences Corporation compare | 7.35% |
| MDT Medtronic PLC | 5.68% |
| ABT Abbott Laboratories compare | 5.62% |
| GEHC GE HealthCare Technologies Inc. compare | 5.45% |
| PHG Koninklijke Philips N.V. compare | 4.21% |
| Medical Devices industry median | −19.7% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on MDT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement